131 related articles for article (PubMed ID: 7127335)
1. Etoposide in the treatment of acute leukemia in adults.
Varini M; Cavalli F; Sauter C
Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
[No Abstract] [Full Text] [Related]
2. Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood.
Rivera G; Bowman WP; Look AT; Evans WE; Kalwinsky D; Dahl GV
Cancer Treat Rev; 1982 Jun; 9 Suppl():53-7. PubMed ID: 6181873
[No Abstract] [Full Text] [Related]
3. [A phase II trial of etoposide (VP-16) administered intravenously in the treatment of malignant lymphoma and acute leukemia].
Moriyama Y; Shibata A; Maekawa I; Yoshida Y; Miura A; Wakui A; Kariyone S; Maekawa T; Miura Y; Abe T
Rinsho Ketsueki; 1985 Nov; 26(11):1774-84. PubMed ID: 3835288
[No Abstract] [Full Text] [Related]
4. Clinical and cell kinetic studies of the effects of the epipodophyllotoxin VP16-213 during therapy of refractory acute nonlymphocytic leukemia.
Look AT; Dahl GV; Rivera G; Mauer AM
Cancer Chemother Pharmacol; 1982; 7(2-3):161-7. PubMed ID: 6177437
[No Abstract] [Full Text] [Related]
5. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
6. Rapid remission induction in adult acute non-lymphoblastic leukaemia.
Dubovsky D; Kernoff L; Jacobs P
Eur J Cancer (1965); 1978 Nov; 14(11):1179-83. PubMed ID: 738325
[No Abstract] [Full Text] [Related]
7. Simple method for the administration of high-dose etoposide during autologous bone marrow transplantation.
Lazarus HM; Creger RJ; Diaz D
Cancer Treat Rep; 1986 Jun; 70(6):819-20. PubMed ID: 3524832
[No Abstract] [Full Text] [Related]
8. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
9. Etoposide (VP-16-213). Current status of an active anticancer drug.
O'Dwyer PJ; Leyland-Jones B; Alonso MT; Marsoni S; Wittes RE
N Engl J Med; 1985 Mar; 312(11):692-700. PubMed ID: 2983208
[No Abstract] [Full Text] [Related]
10. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
[No Abstract] [Full Text] [Related]
11. Podophyllotoxin derivative VP 16-213.
Arnold AM
Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
[TBL] [Abstract][Full Text] [Related]
12. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Kimura K; Yamada K; Yoshida T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
[TBL] [Abstract][Full Text] [Related]
13. Review of etoposide single-agent activity.
Schmoll H
Cancer Treat Rev; 1982 Jun; 9 Suppl():21-30. PubMed ID: 6751532
[No Abstract] [Full Text] [Related]
14. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia].
Esumi N; Todo S; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859
[TBL] [Abstract][Full Text] [Related]
15. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Gutierrez ML; Crooke ST
Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
[No Abstract] [Full Text] [Related]
16. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
[No Abstract] [Full Text] [Related]
17. [VP 16-213 in the treatment of acute leukemia in childhood].
Esumi N; Arakawa S; Imashuku S
Gan To Kagaku Ryoho; 1983 Mar; 10(3):848-51. PubMed ID: 6576730
[TBL] [Abstract][Full Text] [Related]
18. Effective remission induction of refractory childhood acute nonlymphocytic leukemia by VP-16-213 plus azacitidine.
Look AT; Dahl GV; Kalwinsky D; Senzer N; Mason C; Rivera G
Cancer Treat Rep; 1981; 65(11-12):995-9. PubMed ID: 6170431
[TBL] [Abstract][Full Text] [Related]
19. Remission induction in acute myeloid leukaemia with oral etoposide.
Evans JP; Prentice HG
Lancet; 1982 Dec; 2(8311):1345-6. PubMed ID: 6128632
[No Abstract] [Full Text] [Related]
20. [Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].
Labedzki L; Illiger HJ
Blut; 1979 May; 38(5):421-4. PubMed ID: 444681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
